Literature DB >> 16292498

Cerebrospinal fluid catecholamine levels in Japanese encephalitis patients with movement disorders.

U K Misra1, J Kalita, S Pandey, V K Khanna, G Nagesh Babu.   

Abstract

Norepinephrine and dopamine have important role in movement disorders but their role in movement disorders associated with Japanese encephalitis (JE) has not been evaluated. Therefore, in the present study, cerebrospinal fluid (CSF) catecholamine levels and its metabolites in JE patients with movement disorders were compared with those without JE. CSF was collected by lumbar puncture and analyzed by HPLC-ED. Norepinephrine, dopamine and homovanillic acid concentrations were significantly (P<0.005) lower in JE patients compared to control groups. Low levels of catecholamines in JE associated movement disorders compared to idiopathic Parkinson's disease and other extrapyramidal symptoms may be due to severe structural damage to thalamus, basal ganglia and brainstem in JE patients as revealed by MRI findings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16292498     DOI: 10.1007/s11064-005-7414-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  14 in total

1.  Markedly severe dystonia in Japanese encephalitis.

Authors:  J Kalita; U K Misra
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

2.  Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine.

Authors:  M G Ziegler; C R Lake; J H Wood; B R Brooks; M H Ebert
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

3.  DL-threo-3,4-dihydroxyphenylserine for freezing symptom in parkinsonism.

Authors:  H Narabayashi; T Kondo; T Nagatsu; A Hayashi; T Suzuki
Journal:  Adv Neurol       Date:  1984

4.  Dopamine and acetylcholine release in thalamus of non-parkinsonian and parkinsonian subjects.

Authors:  P Malais; A Waltregny; A Maula; A Dresse
Journal:  Acta Neurol Belg       Date:  1990       Impact factor: 2.396

5.  A comparative study on neurochemistry of cerebrospinal fluid in advanced Parkinson's disease.

Authors:  H Liu; R P Iacono; T Schoonenberg; S Kuniyoshi; J Buchholz
Journal:  Neurobiol Dis       Date:  1999-02       Impact factor: 5.996

6.  Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.

Authors:  M A Raskind; E R Peskind; J B Halter; D C Jimerson
Journal:  Arch Gen Psychiatry       Date:  1984-04

7.  Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease.

Authors:  J T Turkka; K K Juujärvi; V V Myllylä
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

8.  Effect of ganglion blockade on cerebrospinal fluid norepinephrine.

Authors:  D S Goldstein; R Zimlichman; G D Kelly; R Stull; J D Bacher; H R Keiser
Journal:  J Neurochem       Date:  1987-11       Impact factor: 5.372

9.  Central nervous system catecholamine metabolism in Korsakoff's psychosis.

Authors:  P R Martin; H Weingartner; E K Gordon; R S Burns; M Linnoila; I J Kopin; M H Ebert
Journal:  Ann Neurol       Date:  1984-02       Impact factor: 10.422

10.  CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.

Authors:  E Eldrup; P Mogensen; J Jacobsen; H Pakkenberg; N J Christensen
Journal:  Acta Neurol Scand       Date:  1995-08       Impact factor: 3.209

View more
  4 in total

Review 1.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 2.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

Review 3.  The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications.

Authors:  Si Shen; Chan Zhang; Yu-Ming Xu; Chang-He Shi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 4.  Viruses, parkinsonism and Parkinson's disease: the past, present and future.

Authors:  Valentina Leta; Daniele Urso; Lucia Batzu; Yue Hui Lau; Donna Mathew; Iro Boura; Vanessa Raeder; Cristian Falup-Pecurariu; Daniel van Wamelen; K Ray Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2022-08-29       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.